Profile data is unavailable for this security.
About the company
BCAL Diagnostics Limited is an Australia-based biotechnology company dedicated to advancing early and accurate breast cancer detection. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. Its non-invasive blood test, BREASTEST plus, is the product in the Company’s BREASTEST range of non-invasive, lipid-based breast cancer diagnostics. BREASTEST plus is a class blood test that measures a panel of lipids, using Liquid Chromatography Mass Spectrometry, to identify a lipidomic breast cancer signature. BREASTEST plus is a rule-out test that has been designed to be used in women with dense breasts and alongside mammography to improve screening and diagnostic outcomes for women.
- Revenue in AUD (TTM)2.65m
- Net income in AUD-7.24m
- Incorporated2010
- Employees--
- LocationBCAL Diagnostics LtdSuite 506, Level 5, 50 Clarence StreetSYDNEY 2000AustraliaAUS
- Websitehttps://www.bcaldiagnostics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control Bionics Ltd | 7.04m | -6.11m | 23.07m | -- | -- | 3.06 | -- | 3.28 | -0.0232 | -0.0232 | 0.0261 | 0.0183 | 0.8158 | 4.99 | 3.35 | -- | -70.78 | -48.07 | -99.30 | -55.80 | 71.14 | 68.24 | -86.77 | -98.27 | 1.08 | -33.30 | 0.0733 | -- | 16.76 | 16.36 | -3.30 | -- | 7.93 | -- |
| ImExHS Ltd | 26.35m | -4.11m | 24.32m | 400.00 | -- | 1.67 | -- | 0.9232 | -0.0861 | -0.0861 | 0.5592 | 0.2693 | 1.18 | 77.60 | 3.32 | 65,869.38 | -18.42 | -17.16 | -27.27 | -22.88 | 34.44 | 32.57 | -15.61 | -21.02 | 1.51 | -10.77 | 0.0863 | -- | 34.41 | 27.47 | 41.00 | -- | -9.90 | -- |
| CONNEQT Health Ltd | 3.55m | -18.19m | 26.94m | 26.00 | -- | 38.21 | -- | 7.58 | -0.0507 | -0.0507 | 0.01 | 0.0012 | 0.3235 | 0.4389 | 10.72 | -- | -165.59 | -99.31 | -618.20 | -249.16 | 71.97 | 84.29 | -511.88 | -208.53 | 0.6557 | -2.37 | 0.8527 | -- | -68.20 | -5.10 | -168.93 | -- | -33.92 | -- |
| Genetic Signatures Ltd | 21.36m | -20.10m | 29.53m | -- | -- | 0.5895 | -- | 1.38 | -0.0899 | -0.0899 | 0.0942 | 0.2205 | 0.3505 | 1.17 | 6.04 | -- | -32.98 | -16.72 | -35.71 | -18.31 | 56.72 | 55.89 | -94.10 | -38.67 | 9.49 | -143.04 | 0.0156 | -- | 49.69 | 8.55 | -12.55 | -- | -17.43 | -- |
| Atomo Diagnostics Ltd | 3.79m | -4.97m | 32.41m | -- | -- | 4.24 | -- | 8.55 | -0.0077 | -0.0077 | 0.0059 | 0.0094 | 0.3672 | 1.07 | 2.83 | -- | -48.13 | -30.62 | -57.46 | -33.10 | 50.62 | 40.54 | -131.08 | -113.09 | 2.27 | -- | 0.0259 | -- | -10.53 | -6.72 | 27.41 | -- | -55.73 | -- |
| ImpediMed Ltd | 12.72m | -23.24m | 36.70m | 77.00 | -- | 1.78 | -- | 2.88 | -0.0115 | -0.0115 | 0.0063 | 0.0101 | 0.2871 | 2.16 | 5.51 | 165,246.80 | -52.43 | -42.33 | -59.33 | -48.49 | 86.25 | 85.16 | -182.62 | -195.14 | 4.71 | -112.78 | 0.4142 | -- | 23.31 | 17.25 | -17.42 | -- | -14.47 | -- |
| Curvebeam AI Ltd | 12.10m | -16.84m | 38.22m | 50.00 | -- | 0.8839 | -- | 3.16 | -0.0453 | -0.0453 | 0.0323 | 0.0905 | 0.1946 | 0.6343 | 10.20 | -- | -27.10 | -- | -31.21 | -- | 44.89 | -- | -139.24 | -- | 1.22 | -80.93 | 0.3366 | -- | 85.33 | -- | 27.09 | -- | -- | -- |
| BCAL Diagnostics Ltd | 2.65m | -7.24m | 44.17m | -- | -- | 7.06 | -- | 16.67 | -0.0201 | -0.0201 | 0.0074 | 0.017 | 0.239 | -- | 0.9573 | -- | -65.31 | -57.98 | -87.92 | -72.00 | -- | -- | -273.21 | -249.54 | -- | -- | 0.2766 | -- | -13.01 | 43.11 | -13.14 | -- | 190.46 | -- |
| HeraMED Ltd | 322.93k | -4.53m | 44.55m | -- | -- | 60.80 | -- | 137.94 | -0.0059 | -0.0059 | 0.0004 | 0.0007 | 0.1381 | 0.3794 | 1.57 | -- | -193.87 | -129.03 | -316.53 | -221.14 | 58.70 | 58.67 | -1,404.05 | -2,178.90 | 2.33 | -- | 0.468 | -- | -39.90 | 11.74 | 18.96 | -- | -- | -- |
| Nova Eye Medical Ltd | 29.27m | -9.06m | 47.00m | 130.00 | -- | 2.47 | -- | 1.61 | -0.0373 | -0.0373 | 0.1183 | 0.0668 | 1.04 | 2.92 | 7.08 | -- | -32.13 | -21.38 | -39.78 | -24.97 | 64.54 | 78.66 | -30.95 | -46.44 | 1.85 | -121.42 | 0.1372 | -- | 24.81 | 17.95 | -3.06 | -- | -14.69 | -- |
| Cleanspace Holdings Ltd | 19.76m | -478.27k | 50.16m | -- | -- | 2.61 | 113.57 | 2.54 | -0.0062 | -0.0062 | 0.2538 | 0.2448 | 0.7372 | 1.95 | 4.94 | -- | -1.78 | -6.87 | -2.07 | -8.29 | 74.76 | 74.57 | -2.42 | -10.49 | 4.46 | -- | 0.1914 | -- | 25.72 | -6.99 | 84.71 | -- | -23.72 | -- |
| Vitasora Health Ltd | 3.71m | -10.11m | 50.17m | 2.00 | -- | 2.90 | -- | 13.54 | -0.0071 | -0.0071 | 0.0027 | 0.0093 | 0.3013 | 0.0106 | 4.17 | -- | -82.17 | -118.94 | -115.44 | -176.54 | 99.19 | 78.72 | -272.73 | -533.63 | 0.6694 | -- | 0.0039 | -- | 256.77 | 10.92 | -41.74 | -- | -- | -- |
| Micro-X Ltd | 13.05m | -13.90m | 58.81m | -- | -- | 7.16 | -- | 4.51 | -0.023 | -0.023 | 0.0214 | 0.0113 | 0.5328 | 0.5665 | 3.51 | -- | -56.71 | -41.13 | -95.63 | -53.72 | 79.05 | 68.51 | -106.45 | -104.84 | 1.13 | -30.40 | 0.464 | -- | -14.25 | 11.56 | -42.29 | -- | -46.10 | -- |
Data as of Feb 16 2026. Currency figures normalised to BCAL Diagnostics Ltd's reporting currency: Australian Dollar AUD
